Ester-based precursors to increase the bioavailability of quercetin

Area of Science:

• Biochemistry
• Pharmacology
• Cell Biology

Background:

• Plant polyphenols, like quercetin, have beneficial properties but poor bioavailability.
• Limited bioavailability hinders in vivo clinical applications of polyphenols.
• Development of precursors resistant to phase II metabolism is crucial for enhanced absorption.

Purpose of the Study:

• To synthesize and evaluate ester derivatives of quercetin as potential precursors with improved bioavailability.
• To assess the stability, solubility, and transport of quercetin derivatives across cell monolayers.
• To investigate the metabolic fate of these derivatives during transepithelial absorption.

Main Methods:

• Synthesis of quercetin ester derivatives, including aminoacyl groups.
• In vitro assessment of compound stability and solubility.
• Modeling transepithelial absorption using MDCK-1, MDCK-2, and Caco-2 cell monolayers.
• Analysis of cellular conjugation and deacylation of quercetin derivatives.

Main Results:

• Quercetin itself underwent extensive conjugation by all cell types tested.
• Some synthesized quercetin derivatives demonstrated partial deacylation and crossed cell monolayers.
• Phase II conjugation was not observed during transport across MDCK cells and some Caco-2 clones.
• Complete deacylation followed by quercetin metabolism occurred in other Caco-2 lines.

Conclusions:

• Ester derivatives of quercetin can improve systemic aglycone concentrations.
• These derivatives show potential for enhanced polyphenol bioavailability.
• Further in vivo studies are warranted to confirm the therapeutic potential of these precursors.